Outlook Therapeutics
OTLK
OTLK
56 hedge funds and large institutions have $89.9M invested in Outlook Therapeutics in 2024 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 0 increasing their positions, 39 reducing their positions, and 47 closing their positions.
Holders
56
Holders Change
-31
Holders Change %
-35.63%
% of All Funds
0.81%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
16
Increased
–
Reduced
39
Closed
47
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
1
BlackRock
New York
|
$6.02M |
2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$4.08M |
3 |
3
Geode Capital Management
Boston,
Massachusetts
|
$1.81M |
4 |
4
State Street
Boston,
Massachusetts
|
$1.79M |
5 |
5
Northern Trust
Chicago,
Illinois
|
$730K |